Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

Ashish Upadhyay; Katrin Uhlig

doi:10.7326/0003-4819-155-3-201108020-00029

Letters |2 August 2011

Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

Ashish Upadhyay, MD; Katrin Uhlig, MD, MS

Article, Author, and Disclosure Information

Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-2790.

IN RESPONSE:

In response to our systematic review of BP targets in CKD trials, Drs. Schrier and Lumlertgul ask whether a lower BP target would benefit patients with CKD and diabetes. They cite the ACCORD and ABCD studies, which we did not include in our review because only one third of participants had CKD on the basis of elevated urinary albumin excretion (about two thirds with microalbuminuria) (1, 2). The ACCORD study did not find a systolic BP target of less than 120 mm Hg to be more beneficial than a target of less than 140 mm Hg for a composite of clinical outcomes. The ABCD trial compared an intensive BP goal (10 mm Hg below the baseline diastolic BP; mean achieved, 128/75 mm Hg) with a more moderate BP goal (diastolic BP of 80 to 89 mm Hg; mean achieved, 137/81 mm Hg) and found benefit for proteinuria but not for kidney function and major cardiovascular outcomes.

FULL TEXT

PDF

Not Available

Letters |2 August 2011

Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

See Also

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

Letters |2 August 2011

Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

See Also

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

You need a subscription to this content to use this feature.